Haan, Germany

Arnold Paeβens

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2009.


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnold Paeβens: Innovator in Chemical Compounds

Introduction

Arnold Paeβens is a notable inventor based in Haan, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to the creation of a patent that showcases his innovative spirit and expertise.

Latest Patents

Arnold Paeβens holds a patent for 3,5-Difluoropyridines. This invention relates to compounds of the formula that have potential applications in various chemical processes. His patent is a testament to his dedication to advancing chemical research and innovation. He has 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Paeβens is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His role at Bayer has allowed him to work on cutting-edge projects that push the boundaries of chemical science. His career is marked by a commitment to excellence and innovation.

Collaborations

Throughout his career, Arnold has collaborated with esteemed colleagues, including Ulrich Niewöhner and Karl-Heinz Schlemmer. These collaborations have enriched his work and contributed to the success of various projects.

Conclusion

In summary, Arnold Paeβens is a distinguished inventor whose work in chemical compounds has made a significant impact. His patent for 3,5-Difluoropyridines exemplifies his innovative contributions to the field. His association with Bayer Aktiengesellschaft further highlights his role in advancing scientific research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…